Call Options

18 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $13.4 Million - $17.6 Million
-332,700 Reduced 10.12%
2,955,200 $123 Million
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $15.4 Million - $17.4 Million
320,700 Added 10.81%
3,287,900 $178 Million
Q4 2023

Feb 13, 2024

BUY
$48.48 - $57.85 $110 Million - $131 Million
2,266,500 Added 323.46%
2,967,200 $152 Million
Q3 2023

May 14, 2024

SELL
$57.89 - $64.73 $131 Million - $147 Million
-2,266,500 Reduced 76.39%
700,700 $40.7 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $31.2 Million - $34.8 Million
538,300 Added 331.47%
700,700 $40.7 Million
Q2 2023

May 14, 2024

BUY
$63.71 - $70.74 $6.91 Million - $7.67 Million
108,400 Added 200.74%
162,400 $10.4 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $6.91 Million - $7.67 Million
108,400 Added 200.74%
162,400 $10.4 Million
Q1 2023

May 14, 2024

SELL
$65.71 - $74.53 $14.2 Million - $16.2 Million
-216,700 Reduced 80.05%
54,000 $3.74 Million
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $14.2 Million - $16.2 Million
-216,700 Reduced 80.05%
54,000 $3.74 Million
Q4 2022

May 14, 2024

BUY
$68.48 - $81.09 $5.54 Million - $6.56 Million
80,900 Added 42.62%
270,700 $19.5 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $5.54 Million - $6.56 Million
80,900 Added 42.62%
270,700 $19.5 Million
Q3 2022

May 14, 2024

SELL
$0.13 - $76.84 $13,611 - $8.05 Million
-104,700 Reduced 35.55%
189,800 $13.5 Million
Q3 2022

Nov 10, 2022

SELL
$0.13 - $76.84 $13,611 - $8.05 Million
-104,700 Reduced 35.55%
189,800 $13.5 Million
Q2 2022

May 14, 2024

SELL
$72.62 - $79.98 $194 Million - $214 Million
-2,672,700 Reduced 90.07%
294,500 $22.7 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $11.9 Million - $13.1 Million
163,600 Added 124.98%
294,500 $22.7 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $23.8 Million - $28.5 Million
-387,000 Reduced 74.72%
130,900 $9.56 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $10.9 Million - $12.7 Million
203,200 Added 64.57%
517,900 $32.3 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $18.6 Million - $21.8 Million
314,700 New
314,700 $18.6 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.